Active substance
Ferric pyrophosphate
- US FDA 3
- Safety 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| TRIFERIC | 27.2MG IRON/5ML (5.44MG IRON/ML); 272MG IRON/50ML (5.44MG IRON/ML) | solution · intravenous | ROCKWELL MEDICAL INC | Discontinued | 23 Jan 2015 |
| TRIFERIC | 272MG IRON/PACKET | powder · intravenous | ROCKWELL MEDICAL INC | Discontinued | 25 Apr 2016 |
| TRIFERIC AVNU | 6.75MG IRON/4.5ML (1.5MG IRON/ML) | solution · intravenous | ROCKWELL MEDICAL INC | Discontinued | 27 Mar 2020 |
Safety signals and safety-related labeling changes
- US FDA 29 Mar 2018 TRIFERIC — safety-related labeling change
Labeling sections changed: Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 29 Mar 2018 TRIFERIC — safety-related labeling change
Labeling sections changed: Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.